ERBB2 and breast carcinoma: The 13th St Gallen International Breast Cancer Conference (2013) defined three main categories and four subcategories of molecular typing, including luminal A/B, Erb-B2 overexpression (HER2-positive) and Basal-like (Triple negative) [3].